This inventor holds 1 USPTO granted patent. Top assignee: Alkaloida Vegyeszeti Gyar. Active years: 1989.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1989
Title: Innovations of Laszlo Czollner in Pharmaceutical Chemistry
Introduction
Laszlo Czollner is a notable inventor based in Budapest, Hungary. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds for medical applications. His work focuses on creating effective treatments for hypertension, showcasing his dedication to improving healthcare.
Latest Patents
Czollner holds a patent for "Novel dihydropyridines having calcium antagonistic and antihypertensive" properties. This invention relates to new substituted dihydropyridine derivatives, which are beneficial for treating pathologically severe hypertension. The compounds exhibit low toxicity and possess an advantageous therapeutic index, making them promising candidates for pharmaceutical development.
Career Highlights
Laszlo Czollner is associated with Alkaloida Vegyeszeti Gyar, a company known for its contributions to the pharmaceutical industry. His work has led to advancements in the treatment of hypertension, reflecting his expertise and commitment to innovation in medicine.
Collaborations
Czollner has collaborated with notable colleagues, including Suzanne Lang Nee Rihmer and Gyongyi Nagy Nee Csokas. These partnerships have likely enhanced the research and development of his patented compounds, fostering a collaborative environment for innovation.
Conclusion
Laszlo Czollner's contributions to pharmaceutical chemistry, particularly through his patented innovations, highlight his role as a significant inventor in the field. His work continues to impact the treatment of hypertension, demonstrating the importance of innovation in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile